Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis
- PMID: 21396644
- DOI: 10.1016/j.atherosclerosis.2011.02.011
Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis
Abstract
Objective: Telomeres and associated proteins are regulators of cellular survival, regeneration and aging. PPAR-γ agonists may mediate vascular effects in addition to insulin sensitizing. We therefore examined whether pioglitazone regulates vascular telomere biology.
Methods and results: C57/Bl6 mice were randomized to treatment with pioglitazone (20mg/kg i.p. daily) or vehicle for 4 weeks (n = 6-8 per group). Telomere repeat amplification protocols showed a 2-fold increase of aortic telomerase activity in the pioglitazone group. Telomere repeat-binding factor 2 protein and mRNA levels (236%+172% of vehicle) as well as phosphorylation of protein kinase Akt (479% of vehicle) were up-regulated. Western blots demonstrated reduced aortic expression of senescence markers p16, cell-cycle checkpoint kinase 2 and p53. These regulatory mechanisms were independent of acute changes of telomere length. Similar observations were made in mononuclear cells (MNC) from these mice and in cultivated bovine aortic endothelial cells, human MNC and endothelial progenitor cells (EPC). Telomerase activation by pioglitazone in cultivated cells was prevented by Akt inhibitors. To test the functional relevance of the findings, isolated mononuclear cells (MNC) were exposed to H(2)O(2). MNC from pioglitazone-treated mice exhibited reduced apoptosis (AnnexinV-FACS). In vivo, lipopolysaccharide-induced aortic endothelial apoptosis was potently prevented in pioglitazone-treated animals (hairpin oligonucleotide assay). Both, up-regulation of telomere-regulating proteins and prevention of oxidative stress-induced aortic apoptosis, were absent in telomerase reverse transcriptase (TERT)-deficient mice.
Conclusions/interpretation: Pioglitazone treatment up-regulates telomerase activity, telomere-stabilizing proteins and reduces senescence markers in vascular cells. These effects and the reduction of LPS-induced endothelial apoptosis by thiazolidinediones depend on TERT. The findings underscore the important role of telomere-regulating proteins for vascular cell function and survival.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Comment in
-
Is telomerase a potential target for vascular rejuvenation?Atherosclerosis. 2011 May;216(1):19-20. doi: 10.1016/j.atherosclerosis.2011.02.015. Epub 2011 Feb 22. Atherosclerosis. 2011. PMID: 21411087 No abstract available.
Similar articles
-
Is telomerase a potential target for vascular rejuvenation?Atherosclerosis. 2011 May;216(1):19-20. doi: 10.1016/j.atherosclerosis.2011.02.015. Epub 2011 Feb 22. Atherosclerosis. 2011. PMID: 21411087 No abstract available.
-
The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells.Atherosclerosis. 2007 May;192(1):67-74. doi: 10.1016/j.atherosclerosis.2006.06.026. Epub 2006 Jul 28. Atherosclerosis. 2007. PMID: 16876172
-
Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis.J Am Coll Cardiol. 2008 Aug 5;52(6):470-82. doi: 10.1016/j.jacc.2008.04.034. J Am Coll Cardiol. 2008. PMID: 18672169
-
Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.J Biomed Mater Res A. 2015 Dec;103(12):3993-4023. doi: 10.1002/jbm.a.35515. Epub 2015 Aug 14. J Biomed Mater Res A. 2015. PMID: 26034007 Review.
-
Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence.Ageing Res Rev. 2008 Apr;7(2):137-46. doi: 10.1016/j.arr.2008.02.001. Epub 2008 Feb 12. Ageing Res Rev. 2008. PMID: 18343732 Review.
Cited by
-
Pioglitazone attenuates valvular calcification induced by hypercholesterolemia.Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):523-32. doi: 10.1161/ATVBAHA.112.300794. Epub 2013 Jan 3. Arterioscler Thromb Vasc Biol. 2013. PMID: 23288158 Free PMC article.
-
Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?Curr Res Pharmacol Drug Discov. 2021 May 13;2:100027. doi: 10.1016/j.crphar.2021.100027. eCollection 2021. Curr Res Pharmacol Drug Discov. 2021. PMID: 34909661 Free PMC article. Review.
-
Telomeres and Telomerase in Cardiovascular Diseases.Genes (Basel). 2016 Sep 1;7(9):58. doi: 10.3390/genes7090058. Genes (Basel). 2016. PMID: 27598203 Free PMC article. Review.
-
Activating the PGC-1α/TERT Pathway by Catalpol Ameliorates Atherosclerosis via Modulating ROS Production, DNA Damage, and Telomere Function: Implications on Mitochondria and Telomere Link.Oxid Med Cell Longev. 2018 Jun 25;2018:2876350. doi: 10.1155/2018/2876350. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30046372 Free PMC article.
-
Functional Role of PPARs in Ruminants: Potential Targets for Fine-Tuning Metabolism during Growth and Lactation.PPAR Res. 2013;2013:684159. doi: 10.1155/2013/684159. Epub 2013 Apr 29. PPAR Res. 2013. PMID: 23737762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous